Althea Group Holdings Limited (ASX:AGH)

ALERT: Price-sensitive ASX Announcement for AGH

Current share price for AGH : $0.020 -0.002 (-9.09%)⁺

Announcement

Appendix 4E Preliminary final report

Release

29 Aug 2025 4:21PM

Price at Release

$0.022

Full Release

Summary

The Appendix 4E Preliminary final report for Althea Group Holdings Limited for the year ended 30 June 2025 highlights a significant decrease in revenue and a reduced loss from ordinary activities after tax compared to the previous year. The company did not declare any dividends and faced challenges such as the liquidation of its UK-based subsidiaries and the winding up of its Australian operations. Capital was raised through multiple share issuances, contributing to an increase in issued capital, although the company reported a comprehensive loss for the year. Althea also established a joint venture, Peak USA JV LLC, during this period.

Key Points

Revenues from ordinary activities decreased by 23.1% to $23,041,000.
Loss from ordinary activities after tax decreased by 74.0% to $8,347,000.
No dividends were paid, recommended, or declared during the financial period.
Althea MMJ UK Limited and MMJ Clinic Group Ireland Limited went into liquidation.
Peak USA JV LLC was established as a 50% joint venture.
Net tangible liabilities per ordinary security were reported at -0.33 cents.
Total comprehensive loss for the year was $8,522,000.
The company raised capital through several share issues, increasing issued capital to $93,969,000.

IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.